Diarrhea

Data indicate that fewer medical students and fellows are joining the HIV workforce, perhaps under the impression that HIV is no longer the exciting and rewarding field it once was. We asked Peter Chin-Hong, MD, professor of medicine and director of the transplant infectious disease program at University of California, San Francisco (UCSF), what the “new HIV” is — the ID-related field that is attracting today’s young clinicians.

Berberine, a supplement originally extracted from the Chinese herb Coptis chinensis, helped to reduce risk for recurrent colorectal adenoma, according to study results.

Individuals who recently used marijuana were less likely to experience constipation, according to study results published in The American Journal of Gastroenterology.

In a Q&A with Healio, gastroenterologists shared how they are handling the recent Zantac recalls in their practices, and Cologuard — a noninvasive colorectal cancer screening test — received FDA approval for at-risk individuals aged 45 years or older.

The American Gastroenterological Association released new clinical practice guidelines for the evaluation of chronic diarrhea.

The FDA has approved new package size and type limits for the over-the-counter, brand-name tablet and capsule forms of loperamide, a diarrhea drug, restricting each carton to no more than 48 mg and requiring unit-dose blister packaging.

Patients with obesity are at greater risk for chronic diarrhea, and the association grew stronger as BMI increased, according to the results of a nationally representative survey.

Although patients with diarrhea- and constipation-predominant irritable bowel syndrome tend to find their condition equally bothersome, they find their lives impacted in different ways, according to survey results.

Passively chlorinating water sources using solid tablet chlorine dosers significantly reduced the rate of childhood diarrhea in two communities in Dhaka, Bangladesh, according to results from a double-blind, cluster-randomized controlled trial published in The Lancet Global Health.

Irritable bowel syndrome is a common gastrointestinal condition, affecting approximately 30 million people in the United States. The hallmark of this condition is change in bowel movements, such as diarrhea, constipation or slow-moving stools. Other symptoms include abdominal pain and cramping, fatigue and more. IBS can be treated by diet or lifestyle changes, medications, or probiotics.